Answer
In healthy adults receiving glecaprevir + pibrentasvir, the steady-state elimination half-lives are 6–9 hours for glecaprevir and 23–29 hours for pibrentasvir.
Sources for this answer
- Glecaprevir/Pibrentasvir 100 mg/40 mg film-coated tabletsAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 25Document updated
Sources checked